Skip to main content
Clinical Trials/NCT01815866
NCT01815866CompletedNot Applicable

Cough-Generated Aerosols of Nontuberculous Mycobacteria in Patients With Cystic Fibrosis

University of Florida1 site in 1 country5 target enrollmentStarted: April 2013Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
5
Locations
1
Primary Endpoint
The number of CF patients who produce culturable aerosols of NTM during coughing.

Study Overview

Brief Summary

Non-tuberculous mycobacteria (NTM) are opportunistic pathogens normally found in soil and water that are being cultured from Cystic Fibrosis (CF) airways at an increasing frequency. They have been demonstrated to cause clinically significant lung disease in some cases and the transmission of NTM, from person to person has been proposed. There are currently no standardized guidelines for isolation of those colonized or infected with NTM.

The investigators will measure particle droplet size from patients with CF who have positive sputum cultures for NTM with the hypothesis that they will be in a range that can spread infection.

Detailed Description

Patients with a positive NTM sputum culture will be asked to participate in the study. If they agree to participate they will sign an informed consent and will be scheduled to come to the University of Florida Clinical Research Center for the testing.

The test will consist of the following: pulmonary function test, collecting a sputum culture if possible, coughing for 5 minutes into a tube connected to a canister, hypertonic saline and albuterol will be given after the 5 minutes of coughing and then they would repeat with another 5 minutes of coughing. There can be a break inbetween the coughing if needed.

Patients maybe asked to come back a second time if they develop a different type of NTM or start treatment for NTM.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Prospective

Eligibility Criteria

Ages
8 Years to 75 Years (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age greater than or equal to age 8 years
  • Confirmed Diagnosis of CF
  • Sputum/Throat/Bronchoscopic culture positive for NTM within the last 12 months

Exclusion Criteria

  • Pregnancy
  • Pneumothorax within the last 6 months
  • Forced Expiratory Volume at one second <30% predicted
  • Hemoptysis greater than 1 tablespoon within the last 7 days

Outcomes

Primary Outcomes

The number of CF patients who produce culturable aerosols of NTM during coughing.

Time Frame: 6 weeks

Patients with CF and a positive sputum or bronchoalveolar lavage (BAL) culture for NTM will cough into a chamber filled with culture plates that can measure droplet size. The investigators are looking for large droplets, that could land on surfaces and be a source for infection transmission, as well as fine droplets(5 microns or less)that are consistent with airborne transmission.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials